Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Pulmonary Embolism III: Nursing Management01:27

Pulmonary Embolism III: Nursing Management

320
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
320
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

277
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
277
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

464
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
464
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

262
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
262
Pneumothorax-II01:27

Pneumothorax-II

852
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
852
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

3.1K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
3.1K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

MRE11 Deficiency Occurs in a Small Group of Cancers from Various Different Tumor Entities.

Diagnostics (Basel, Switzerland)·2026
Same author

A case of Schöpf-Schulz-Passarge syndrome presented with widespread apocrine hidrocystomas showing variable clinical features.

Acta dermatovenerologica Croatica : ADC·2026
Same author

Prevalence of heterozygous and homozygous 9p21 deletions in human cancer: a tissue microarray study on 4,999 tumors from 125 different tumor types.

Molecular medicine (Cambridge, Mass.)·2026
Same author

Neuromuscular Electrical Stimulation in Brachial Plexus Birth Injury Rehabilitation: A Systematic Review.

Medicina (Kaunas, Lithuania)·2026
Same author

Klinische Padiatrie·2026
Same author

Down Syndrome: From Pregnancy through Childhood in Türkiye.

Molecular syndromology·2026

相关实验视频

Updated: Jan 8, 2026

Pulmonary Embolism III: Nursing Management
01:27

Pulmonary Embolism III: Nursing Management

Published on: June 19, 2025

320

人类CLP1突变改变了tRNA生物发生,影响了外周和中枢神经系统的功能.

Ender Karaca1, Stefan Weitzer2, Davut Pehlivan1

  • 1Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.

Cell
|April 29, 2014
PubMed
概括

对于RNA处理至关重要的CLP1基因的突变会导致严重的神经障碍,影响运动功能和大脑发育. 这突显了罕见的遗传变异在人类疾病中的作用.

更多相关视频

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Published on: June 19, 2025

277
Pulmonary Embolism I: Introduction
01:29

Pulmonary Embolism I: Introduction

Published on: June 19, 2025

464

相关实验视频

Last Updated: Jan 8, 2026

Pulmonary Embolism III: Nursing Management
01:27

Pulmonary Embolism III: Nursing Management

Published on: June 19, 2025

320
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Published on: June 19, 2025

277
Pulmonary Embolism I: Introduction
01:29

Pulmonary Embolism I: Introduction

Published on: June 19, 2025

464

科学领域:

  • 神经科学是一个神经科学.
  • 遗传学 遗传学 是一个
  • 分子生物学分子生物学

背景情况:

  • CLP1 (CASEIN LYSINE RICH PROTEIN 1) 是一种RNA激酶,对于tRNA拼接至关重要.
  • 在小鼠中,激酶死亡的CLP1导致神经肌肉疾病,包括运动神经元损失和.
  • 人们越来越认识到CLP1在神经发育中的作用.

研究的目的:

  • 研究CLP1突变在人类神经系统疾病中的作用.
  • 阐明CLP1相关的神经现象型的基础分子机制.
  • 探索疾病病因学中罕见遗传变异的意义.

主要方法:

  • 人类基因组分析以确定受影响家族中的CLP1突变.
  • 生物化学测试以评估CLP1与TSEN复合体的相互作用和tRNA分裂前活动.
  • 受影响个体的表型分析和CLP1激酶死亡的小鼠模型.

主要成果:

  • 在五个家族中发现了一种同卵性CLP1误解突变 (p.R140H),导致与TSEN复合体相互作用的丧失.
  • 突变导致tRNA前分裂减少,线性tRNA内核的积累,以及严重的运动感官缺陷.
  • 受影响的个体和小鼠表现出小头症和皮质失生,这是由于增强的神经元前代细胞死亡.

结论:

  • CLP1突变会损害tRNA剪接,导致一个独特的神经综合征.
  • 这项研究强调了CLP1在神经元发育和大脑形成中的关键作用.
  • 这项研究强调了罕见遗传变异的重要性,并支持了家族基因组学假说.